MSD Announces Results from Phase 2/3 ... - HFI Connect - Hep...

HFI Connect - Hepatitis

959 members1,215 posts

MSD Announces Results from Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy

kuzoigwe profile image
0 Replies

Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease

C-SURFER Trial is First to Investigate an All-Oral Ribavirin-Free Hepatitis C Treatment Regimen in Treatment-Naïve and Treatment-Experienced Patients with Advanced Chronic Kidney Disease Infected with Hepatitis C Virus Genotype 1

businesswire.com/news/home/...

Written by
kuzoigwe profile image
kuzoigwe
To view profiles and participate in discussions please or .
Read more about...